Cardiology (all articles)
Randomized Trial: 0/1-hour High-sensitivity Cardiac Troponin T Protocol Enables Faster Discharge of Patients with Suspected Acute Coronary Syndrome
12 Nov, 2019 | 11:20h | UTCA Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes – Circulation (free for a limited period)
Commentaries: World-First Trial Cuts ED Wait Times and Admissions – Flinders University (free) AND Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT – TCTMD (free)
Related Studies/Commentaries Highlighting Problems with High-sensitivity Cardiac Troponin: Myths in Emergency Medicine: Is hs-cTnT Worth the Downstream Testing? – Emergency Medicine News (free) AND Randomized Trial: High-Sensitivity Troponin in the Evaluation of Suspected Acute Coronary Syndrome – The Lancet (free study and commentaries) AND Cohort Study: The Introduction of High-sensitive Troponins Had No Impact on Survival – Journal of the American College of Cardiology (free) AND Cohort Study: High Sensitivity Cardiac Troponin May Result in Misdiagnosis of Acute Myocardial Infarction – The BMJ (free)
Review: Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
12 Nov, 2019 | 10:50h | UTC
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology – 2019
10 Nov, 2019 | 13:59h | UTCRelated Guidelines: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (free guideline and resources) AND Cardiovascular disease: risk assessment and reduction, including lipid modification – National Institute for Health and Care Excellence (free) AND Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update – Canadian Medical Association Journal (free)
FDA Safety Communication: Biotin Supplements May Result in Falsely Low Troponin Results
10 Nov, 2019 | 13:43h | UTCCommentary: FDA Updates Warning on Biotin Interfering with Lab Results – NEJM Journal Watch (free)
“…the FDA is particularly concerned about biotin interference causing a falsely low result for troponin, a clinically important biomarker to aid in the diagnosis of heart attacks, which may lead to a missed diagnosis and potentially serious clinical implications. The FDA continues to receive adverse events reports indicating biotin interference caused falsely low troponin results.”
Cardiovascular Risk of Electronic Cigarettes: A Review of Preclinical and Clinical Studies
8 Nov, 2019 | 08:22h | UTCCommentaries: Vaping not worth potential heart risk, researchers say – Ohio State University (free) AND Vaping risks significant, says new review – News Medical (free) AND E-cigs may damage the heart, study says – MedicalXpress (free)
AHA Scientific Statement: Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap
8 Nov, 2019 | 08:38h | UTCCommentary: The Management of Subclinical Atrial Fibrillation: The Pathway to True Medical Expertise – American Heart Association (free)
Top Things to Know: Subclinical and Device-Detected Atrial Fibrillation (free)
Related: Apple Watch Can Spot Atrial Fibrillation, But More Research is Needed (several commentaries on the subject)
Insomnia Symptoms and Risk of Cardiovascular Diseases Among 0.5 Million Adults: A 10-year Cohort
8 Nov, 2019 | 07:11h | UTCCommentaries: Difficulty sleeping linked with raised risk of heart attack and stroke – NHS Choices (free) AND Insomnia in adults linked to heart attack and stroke – CNN (free) AND Insomnia maybe a significant risk factor for heart attacks and strokes – News Medical (free)
[Abstract Only] Study: Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
8 Nov, 2019 | 06:42h | UTCDistinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: World’s most comprehensive study of a deadly heart condition yields 1st results – University of Virginia Health System (free) AND Hypertrophic Cardiomyopathy Registry Subgroups – American College of Cardiology (free)
Related Commentary on Twitter
Are there subgroups in the hypertrophic #cardiomyopathy population? New #JACC study looks at #cvImaging characteristics using data from the HCMR registry. https://t.co/hImlr841RB @ChrisKramerMD @CardioUva pic.twitter.com/JyLlRh6uP9
— JACC Journals (@JACCJournals) November 6, 2019
Position Statement for Transcatheter Aortic Valve Implantation
7 Nov, 2019 | 08:12h | UTCRelated Guidelines: Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) – Clinical Research in Cardiology (free) AND 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease (free) AND 2017 ESC/EACTS Guidelines for the management of valvular heart disease (free)
Ten Things ICU Specialists Need to Know About New Valvular Procedures in Interventional Cardiology
7 Nov, 2019 | 08:11h | UTC
Executive Summary: HRS Consensus Statement on the Management of Arrhythmogenic Cardiomyopathy
7 Nov, 2019 | 08:13h | UTCFull Guideline: 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy (free guideline and commentary)
Cohort Study: Metformin Use Linked to Lower Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes
7 Nov, 2019 | 07:40h | UTCCommentary: Metformin lowers risk of HF hospitalization in those with T2D – Cardiovascular Business (free)
Related Study: Metformin Use Linked to Reduced Risk for Cardiovascular Death and All-cause Mortality (link to abstract and commentaries)
Consensus Document: Follow-up of Patients after Revascularization for Peripheral Arterial Diseases
5 Nov, 2019 | 10:20h | UTC
Cohort Study: Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality
5 Nov, 2019 | 08:03h | UTCEditorial: The Pressure Is On: Implications of Blood Pressure After Aortic Valve Replacement (free)
Meta-Analysis: Calcium Supplementation May Increase the Risk of Myocardial Infarction
1 Nov, 2019 | 07:42h | UTCRelated Meta-Analysis with Conflicting Results: Calcium Intake and Cardiovascular Disease Risk: An Updated Systematic Review and Meta-analysis – Annals of Internal Medicine (free)
See also: Meta-Analysis: Calcium and Vitamin D Not Helpful to Reduce the Risk of Fractures (free)
[Abstract Only] Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
31 Oct, 2019 | 08:16h | UTCRisk of Mortality Following Catheter Ablation of Atrial Fibrillation – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: Mortality Risk After Catheter Ablation of Atrial Fibrillation – American College of Cardiology (free) AND Early mortality ‘a very real complication’ after catheter ablation of AFib – Cardiovascular Business (free) AND Afib Ablation Deaths Do Happen – MedPage Today (free registration required)
Related Commentary on Twitter
New #JACC study finds early mortality following #AFib ablation occurs in 1/200 patients, with most deaths occurring during 30-day readmission. https://t.co/kwl1yRFza4 pic.twitter.com/Kh9utLctd0
— JACC Journals (@JACCJournals) October 29, 2019
[Abstract Only] Meta-analysis: Double Anti-thrombotic Therapy Safer than Triple Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
30 Oct, 2019 | 08:14h | UTCMeta-analysis comparing double versus Triple Anti-thrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease – The American Journal of Cardiology (link to abstract – $ for full-text)
Commentary: Meta-analysis: Dual therapy yields less bleeding than triple therapy in AF, CAD – Healio (free registration required)
Related Randomized Trial: Dual Antithrombotic Therapy after PCI in Atrial Fibrillation (free study and commentaries)
Related Meta-Analysis: Dual vs. Triple Antithrombotic Therapy in Patients with Atrial Fibrillation following PCI (free) AND Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention (link to abstract)
Study Commentary: Short-term Dual Antiplatelet Treatment May Be Best for Most Patients After Receiving a Drug-eluting Stent
29 Oct, 2019 | 02:36h | UTCOriginal Study: Meta-Analysis: Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-eluting Stent (free)
[Abstract Only] Study: New Onset Atrial Fibrillation Linked to Poor Outcomes Following TAVR
29 Oct, 2019 | 02:11h | UTCImpact of Pre-Existing and New Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)
Commentaries: New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR – TCTMD (free) AND More Evidence of Worse Outcomes With New-Onset AFib After TAVR – Medscape (free registration required)
Imaging in ESC Clinical Guidelines: Chronic Coronary Syndromes
27 Oct, 2019 | 19:23h | UTCOriginal Guideline: 2019 ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes (free)
Myocardial Fibrosis: Why Image, How to Image and Clinical Implications
27 Oct, 2019 | 19:22h | UTCMyocardial fibrosis: why image, how to image and clinical implications – Heart (free)
[Abstract Only] Large Observational Analysis Suggests Thiazide Diuretics are Superior as First-Line Drugs for the Treatment of Hypertension
25 Oct, 2019 | 08:48h | UTCComprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis – The Lancet (link to abstract – $ for full-text)
Commentaries: Most Prescribed Blood Pressure Drugs May Be Less Effective than Others – Columbia University Irving Medical Center (free) AND Diuretics Better Than ACE Inhibitors as Initial Hypertension Treatment, Analysis Suggests – NEJM Journal Watch (free)
Related Cochrane Review: Thiazides best first choice for hypertension (free)
Perspective: The Silent Heart Attack You Didn’t Know You Had
25 Oct, 2019 | 08:38h | UTCThe Silent Heart Attack You Didn’t Know You Had – The New York Times (10 articles per month are free)
Related Studies: Silent Myocardial Infarction Often Precedes Sudden Cardiac Death (link to abstract and commentaries) AND Cohort Study: Long-term Outcomes of Unrecognized MI (link to abstract and commentaries)
The 2018 ESC/ESH Hypertension Guideline and the 2019 NICE Hypertension Guideline, How and Why they Differ
24 Oct, 2019 | 08:37h | UTCOriginal Guidelines: 2018 ESC/ESH Guidelines for the management of arterial hypertension – European Heart Journal (free) AND Hypertension in adults: diagnosis and management – National Institute for Health and Care Excellence (free)
[Abstract Only] Practice Changing? – Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial
23 Oct, 2019 | 08:23h | UTCBedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial – European Heart Journal (link to abstract – $ for full-text)
Commentaries: Blood pressure pills ‘work better at bedtime’ – BBC (free) AND You might want to change the time of day you take your blood pressure medicine – CNN (free) AND Expert reaction to study looking at the time of day when blood pressure medication is taken and cardiovascular disease risk – Science Media Centre (free)